| Property | Value |
|---|
|
?:abstract
|
-
Introduction: The COVID-19 pandemic has challenged hematopoietic stem cell transplant (HSCT) clinicians to profoundly reorganize their medical care to reduce complications without compromising patients\' inquiries Since this pandemic is a foggy novel disease, scientific approved data are not available, and so decisions should be made based on expert opinions Methods: This is a pediatric HSCT center experience, including preventive and solving strategies specifically undertaken to address problems caused by the COVID-19 outbreak Results: In this report, we have shared our experience to alert healthcare professionals worldwide to get prepared accordingly Conclusion: We are not aware of the duration or outcome of the pandemic, but we are intended to learn from our experiences and figure out the best strategies to minimize the possible harms
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
Archives_of_Pediatric_Infectious_Diseases
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Pediatric Hematopoietic Stem Cell Transplant in the COVID-19 Pandemic: The Problems We Faced and The Strategies We Adopted
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}